ARCHIVES

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | March 14, 2008

Download PDF Visit The Full Archive

Related Articles

Urgent Need For New Drugs To Treat Pre-Cancers: AACR.

March 1, 2002

Funding Opportunities

September 20, 2002

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995

The Cancer Letter’s Paul Goldberg Wins Journalism Award

April 10, 2009

In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State

February 14, 1997